Results 121 to 130 of about 12,784,255 (313)

The role of autophagy in resistance to targeted therapies.

open access: yesCancer Treatment Reviews, 2020
Autophagy is a self-degradative cellular process, involved in stress response such as starvation, hypoxia, and oxidative stress. This mechanism balances macro-molecule recycling to regulate cell homeostasis.
L. Mele   +9 more
semanticscholar   +1 more source

Sales of selected targeted cancer therapies over time.

open access: yes, 2015
Sales of selected targeted cancer therapies over time.
Rosarin Sruamsiri (687533)   +4 more
core   +1 more source

Effect of DFPP on Ferroptosis in Peripheral Blood CD14+ Monocytes of Hyperlipidemic Patients Involving the ACSL4/LPCAT3/ALOX5 Pathway

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Hyperlipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Although statins are the cornerstone of lipid‐lowering therapy, their use may be limited in some patients by adverse effects. This study evaluated the possible impact of non‐drug treatment using double‐filtration plasmapheresis (DFPP) on CD14+
Yun Cheng   +3 more
wiley   +1 more source

Adaptive mutability of colorectal cancers in response to targeted therapies

open access: yesScience, 2019
A cross-kingdom tale of drug resistance Physicians who treat bacterial infections and those who treat cancer often face a common challenge: the development of drug resistance.
M. Russo   +22 more
semanticscholar   +1 more source

Recent Advances in Targeted Therapies for Infantile Hemangiomas [PDF]

open access: yes
Tiantian Liang,1,* Xianbin Liu,1,* Yujun Tong,2 Qian Ding,3 Min Yang,1 Hong Ning1 1Department of Pharmacy, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, People’s ...
Liu X   +5 more
core  

Cost-effectiveness of targeted therapies licensed with companion biomarkers.

open access: yes, 2018
Cost-effectiveness of targeted therapies licensed with companion biomarkers.
Mikyung Kelly Seo (5793935)   +1 more
core   +1 more source

The Impact of Tenapanor on Body Composition and Blood Pressure in Peritoneal Dialysis Patients: A Pilot Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Instruction Tenapanor potentially affects fluid volume and blood pressure. This study explored its effects on these parameters in patients undergoing peritoneal dialysis (PD). Methods We conducted a single‐arm, prospective observational study that enrolled 10 patients on PD with hyperphosphatemia who were newly initiated on tenapanor.
Shun Yoshida   +11 more
wiley   +1 more source

Rescue of exhausted CD8 T cells by PD-1 targeted therapies is CD28-dependent

open access: yesScience, 2017
Immunotherapeutic PD-1–targeted therapies require CD28 to promote cancer cell killing. CD28 is a critical target for PD-1 blockade PD-1–targeted therapies have been a breakthrough for treating certain tumors and can rejuvenate T cells to unleash the ...
A. Kamphorst   +19 more
semanticscholar   +1 more source

Therapeutic Apheresis in Nigeria: Awareness, Knowledge Gaps, and Readiness for Service Expansion Among Healthcare Professionals

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is a specialized extracorporeal blood purification modality used in the management of complex hematologic, neurologic, and autoimmune diseases. Despite established global guidelines, its utilization in Nigeria remains largely undocumented.
Chimezie G. Okwuonu   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy